← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2008Last known activity
Nov 1, 2012
Timeline
1980s
- Jan 1, 1986
Texas Oncology Cancer Center— Founded
Drugs by trial phase (13 distinct, 4 trials)
Phase 2 (13 own, 0 via acquisition)
Indications
Studied for
- Anemia, Aplastic
- Hodgkin Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Multiple Myeloma
- Multiple Sclerosis
- Myelodysplastic Syndromes
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Sclerosis
- Stomach Neoplasms
- Syndrome
Recent trials (7)
- NCT01679041Sponsor investigatorPhase 2Nov 1, 2012
- NCT01500161Lead sponsorPhase 2Nov 1, 2011
- NCT01500161Reponsible party - principal investigatorPhase 2Nov 1, 2011
- NCT00911820CollaboratorPhase 2Jul 1, 2009
- NCT00700011Lead sponsorPhase 2Mar 1, 2008
- NCT00700011Reponsible party - principal investigatorPhase 2Mar 1, 2008
- NCT00700011Overall official - principal investigatorPhase 2Mar 1, 2008
Details
- Founded
- TX, US Jan 1, 1986
- Last known activity
- Nov 1, 2012